article · Journal of Clinical Cardiology
Cardiovascular diseases continue to be a primary global cause of death and illness, driving the need for better prevention and treatment methods. Conventional preventive measures, such as healthy dietary habits, regular physical exercise, smoking cessation, and medications like statins and blood pressure treatments, remain fundamental. Alongside these, emerging techniques such as genetic testing, targeted risk profiling, and mobile health tools are expanding prevention options. Disease management has also progressed, with acute treatments like reperfusion and stroke care improving survival, while chronic care benefits from modern heart failure therapies and implantable devices. Furthermore, precision healthcare, artificial intelligence tools, regenerative therapies, and traditional Chinese medicine are under investigation. Realising the benefits of these advances requires tackling practical obstacles, notably healthcare costs, inequitable access, and reluctance to update established clinical routines.
Cardiovascular conditions affect millions of people across the globe and place heavy strains on healthcare systems. Summarising existing therapies alongside novel innovations helps clinicians and policymakers understand modern cardiac care. Identifying barriers like treatment expense and delivery hurdles is vital to ensuring that new medical technologies successfully reach patients who need them most.
Potential commercial applications span digital health platforms, artificial intelligence diagnostic software, genetic screening kits, and specialised medical devices for heart failure. Target users include cardiologists, hospital networks, and at-risk patients. Because this is a broad review outlining both established practices and experimental concepts like regenerative medicine, individual technologies range from currently marketed products to early-stage research facing market-entry hurdles such as cost and clinical adoption resistance.
AI-generated from the published abstract. Always read the original work before citing.
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Effective prevention and management strategies are essential to reduce the burden of CVDs. This review summarizes recent advances in the prevention and management of CVDs. In terms of prevention, lifestyle modifications, such as diet, exercise, and smoking cessation, remain important strategies. Pharmacological interventions, including statins, antiplatelet agents, and antihypertensive medications, have also shown benefits. Innovative approaches, such as genetic testing and risk stratification, targeted prevention strategies, and the use of mobile health technology, are being explored. In terms of management, acute management strategies, such as reperfusion therapy for myocardial infarction, acute heart failure management, and stroke management, have improved outcomes. Chronic management strategies, including medical therapy for heart failure, arrhythmia management, and device therapy for heart failure, have also shown benefits. Innovative approaches, such as precision medicine and personalized treatment, the use of artificial intelligence in diagnosis and treatment, and advances in traditional Chinese and regenerative medicine, are being investigated. While recent advances in the prevention and management of CVDs are promising, challenges remain in implementing these strategies, including cost-effectiveness, access to care, and resistance to change in clinical practice. Continued research and innovation are essential to reduce the burden of CVDs and improve patient outcomes.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.33696/cardiology.5.048
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
